Antimicrobial Resistance of Helicobacter pylori Isolates in Korea
Antimicrobial resistance is a growing problem in the eradication of Helicobacter pylori. A combination therapy with proton pump inhibitor, clarithromycin, and amoxicillin is recommended as the first-line treatment regimen in Korea. However, the eradication rate with a standard triple therapy has bee...
Main Authors: | Eun Jeong Gong, Ji Yong Ahn |
---|---|
Format: | Article |
Language: | English |
Published: |
Yong Chan Lee
2018-06-01
|
Series: | The Korean Journal of Helicobacter and Upper Gastrointestinal Research |
Subjects: | |
Online Access: | http://www.helicojournal.org/journal/view.html?doi=10.7704/kjhugr.2018.18.2.82 |
Similar Items
-
The Prevalence of Multidrug Resistance of <i>Helicobacter pylori</i> and Its Impact on Eradication in Korea from 2017 to 2019: A Single-Center Study
by: Jae Yong Park, et al.
Published: (2020-09-01) -
Antimicrobial resistance of Helicobacter pylori in Smolensk
by: Dekhnich N.N., et al.
Published: (2018-02-01) -
Antimicrobial Susceptibility of Helicobacter pylori Isolates from Patients with Gastric Cancer and Precancer
by: Morozova L.G., et al.
Published: (2016-11-01) -
New Helicobacter pylori Eradication Therapies
by: Jae Yong Park, et al.
Published: (2018-11-01) -
Increasing antimicrobial resistance of Helicobacter pylori infection among Saudi patients undergoing upper gastrointestinal endoscopy
by: Fahad A.S. Al-Eidan, et al.
Published: (2017-05-01)